New York City pledged this week to pay down $2 billion worth of residents’ medical debt. In doing so, it has come around to an innovation, started in the Midwest, that’s ridding millions of Americans of health care debt.
Pembrolizumab Wins FDA Approval in Operable Lung Cancer
The FDA approved pembrolizumab (Keytruda) on Monday in combination with platinum-based chemotherapy for the perioperative treatment of resectable non-small cell lung cancer (NSCLC). Approval was
October 18, 2023